Coverage
-
November 25, 2019
A Delaware federal jury late Monday hit Roche Diagnostics Corp. with a roughly $137.3 million verdict for willfully infringing three of Meso Scale Diagnostic LLC's laboratory testing system patents, Meso's counsel said.
1 other articles on this case.
View all »